Engineered as a centralised high-capacity system, a single HDR unit can support up to 40 operating theatres, or a combination of theatres and recovery bays. This centralisation not only reduces increased capital outlay for multiple single-room units but also avoids risk from any new infection-control hazards, as no equipment is introduced into the operating theatres.
HDR’s processing efficiency of 99.99 per cent directly supports NHS Net Zero targets. Critically, HDR interfaces seamlessly with existing AGSS infrastructure. There is also no alteration to either anaesthetic machines or theatre staff workflows and therefore no training is required for use for clinical staff.
The plantroom-based HDR’s collection tanks require replacement every 3 to 6 months. The system is fitted with remote monitoring for instant notification of tank replacement. This predictable servicing interval contrasts favourably with the more labour-intensive demands of decentralised capture devices.
The HDR system has a decade of proven installations across Canada and the USA, where the platform has consistently demonstrated technical reliability, environmental impact reduction, and long-term operational resilience. It delivers a rigorously validated, lowtouch, high-performing solution that aligns clinical practicality with sustainability targets.
BeaconMedaes is a global leader in medical gas pipeline system (MGPS) solutions, with services including preventative maintenance contracts, equipment servicing, installation and commissioning, site surveys and design to HTM 02-01 standards. BeaconMedaes has been a trusted supplier to NHS and private hospitals for nearly 50 years and is owned by Atlas Copco, a well-established and world-leading provider of industrial productivity solutions.